US2699808A
(en)
|
1944-10-06 |
1955-01-18 |
Mark W Lowe |
Apparatus for peeling tomatoes
|
US2699508A
(en)
|
1951-12-21 |
1955-01-11 |
Selectronics Inc |
Method of mounting and construction of mounting for low frequency piezoelectric crystals
|
US5118800A
(en)
|
1983-12-20 |
1992-06-02 |
California Institute Of Technology |
Oligonucleotides possessing a primary amino group in the terminal nucleotide
|
FR2567892B1
(fr)
|
1984-07-19 |
1989-02-17 |
Centre Nat Rech Scient |
Nouveaux oligonucleotides, leur procede de preparation et leurs applications comme mediateurs dans le developpement des effets des interferons
|
US5166315A
(en)
|
1989-12-20 |
1992-11-24 |
Anti-Gene Development Group |
Sequence-specific binding polymers for duplex nucleic acids
|
US5185444A
(en)
|
1985-03-15 |
1993-02-09 |
Anti-Gene Deveopment Group |
Uncharged morpolino-based polymers having phosphorous containing chiral intersubunit linkages
|
US5034506A
(en)
|
1985-03-15 |
1991-07-23 |
Anti-Gene Development Group |
Uncharged morpholino-based polymers having achiral intersubunit linkages
|
US5506337A
(en)
|
1985-03-15 |
1996-04-09 |
Antivirals Inc. |
Morpholino-subunit combinatorial library and method
|
US5591722A
(en)
|
1989-09-15 |
1997-01-07 |
Southern Research Institute |
2'-deoxy-4'-thioribonucleosides and their antiviral activity
|
DK0497875T3
(da)
|
1989-10-24 |
2000-07-03 |
Gilead Sciences Inc |
2'-modificerede oligonukleotider
|
US5670633A
(en)
|
1990-01-11 |
1997-09-23 |
Isis Pharmaceuticals, Inc. |
Sugar modified oligonucleotides that detect and modulate gene expression
|
US5646265A
(en)
|
1990-01-11 |
1997-07-08 |
Isis Pharmceuticals, Inc. |
Process for the preparation of 2'-O-alkyl purine phosphoramidites
|
GB9009980D0
(en)
|
1990-05-03 |
1990-06-27 |
Amersham Int Plc |
Phosphoramidite derivatives,their preparation and the use thereof in the incorporation of reporter groups on synthetic oligonucleotides
|
DE69032425T2
(de)
|
1990-05-11 |
1998-11-26 |
Microprobe Corp., Bothell, Wash. |
Teststreifen zum Eintauchen für Nukleinsäure-Hybridisierungsassays und Verfahren zur kovalenten Immobilisierung von Oligonucleotiden
|
US6582908B2
(en)
|
1990-12-06 |
2003-06-24 |
Affymetrix, Inc. |
Oligonucleotides
|
US5877160A
(en)
|
1991-05-31 |
1999-03-02 |
Genta Incorporated |
Compositions and methods of treatment of androgen-associated baldness using antisense oligomers
|
US7517644B1
(en)
|
1991-08-23 |
2009-04-14 |
Larry J. Smith |
Method and compositions for cellular reprogramming
|
EP0538194B1
(de)
|
1991-10-17 |
1997-06-04 |
Novartis AG |
Bicyclische Nukleoside, Oligonukleotide, Verfahren zu deren Herstellung und Zwischenprodukte
|
US5359044A
(en)
|
1991-12-13 |
1994-10-25 |
Isis Pharmaceuticals |
Cyclobutyl oligonucleotide surrogates
|
FR2687679B1
(fr)
|
1992-02-05 |
1994-10-28 |
Centre Nat Rech Scient |
Oligothionucleotides.
|
EP0577558A2
(de)
|
1992-07-01 |
1994-01-05 |
Ciba-Geigy Ag |
Carbocyclische Nukleoside mit bicyclischen Ringen, Oligonukleotide daraus, Verfahren zu deren Herstellung, deren Verwendung und Zwischenproduckte
|
JPH08504559A
(ja)
|
1992-12-14 |
1996-05-14 |
ハネウエル・インコーポレーテッド |
個別に制御される冗長巻線を有するモータシステム
|
CA2156512C
(en)
|
1993-02-19 |
2002-11-19 |
Mary Ellen Harper |
Treatment of androgen-associated baldness using antisense oligomers
|
EP0691968B1
(en)
|
1993-03-30 |
1997-07-16 |
Sanofi |
Acyclic nucleoside analogs and oligonucleotide sequences containing them
|
US5801154A
(en)
|
1993-10-18 |
1998-09-01 |
Isis Pharmaceuticals, Inc. |
Antisense oligonucleotide modulation of multidrug resistance-associated protein
|
US5556956A
(en)
|
1993-11-04 |
1996-09-17 |
Board Of Regents, The University Of Texas System |
Methods and compositions relating to the androgen receptor gene and uses thereof
|
US5446137B1
(en)
|
1993-12-09 |
1998-10-06 |
Behringwerke Ag |
Oligonucleotides containing 4'-substituted nucleotides
|
US5519134A
(en)
|
1994-01-11 |
1996-05-21 |
Isis Pharmaceuticals, Inc. |
Pyrrolidine-containing monomers and oligomers
|
US5627053A
(en)
|
1994-03-29 |
1997-05-06 |
Ribozyme Pharmaceuticals, Inc. |
2'deoxy-2'-alkylnucleotide containing nucleic acid
|
US5597909A
(en)
|
1994-08-25 |
1997-01-28 |
Chiron Corporation |
Polynucleotide reagents containing modified deoxyribose moieties, and associated methods of synthesis and use
|
WO1997011170A1
(en)
|
1995-09-20 |
1997-03-27 |
Worcester Foundation For Biomedical Research |
Antisense oligonucleotide chemotherapy for benign hyperplasia or cancer of the prostate
|
US6300060B1
(en)
|
1995-11-09 |
2001-10-09 |
Dana-Farber Cancer Institute, Inc. |
Method for predicting the risk of prostate cancer morbidity and mortality
|
US5656408A
(en)
|
1996-04-29 |
1997-08-12 |
Xerox Corporation |
Coated carrier particles
|
US6489163B1
(en)
|
1996-05-08 |
2002-12-03 |
Board Of Regents, The University Of Texas System |
Ribozyme mediated inactivation of the androgen receptor
|
US6770748B2
(en)
|
1997-03-07 |
2004-08-03 |
Takeshi Imanishi |
Bicyclonucleoside and oligonucleotide analogue
|
JP3756313B2
(ja)
|
1997-03-07 |
2006-03-15 |
武 今西 |
新規ビシクロヌクレオシド及びオリゴヌクレオチド類縁体
|
US5994076A
(en)
|
1997-05-21 |
1999-11-30 |
Clontech Laboratories, Inc. |
Methods of assaying differential expression
|
EP2253639A1
(en)
|
1997-09-12 |
2010-11-24 |
Exiqon A/S |
Bi- and tri-cyclic nucleoside, nucleotide and oligonucleoide analogues
|
US6794499B2
(en)
|
1997-09-12 |
2004-09-21 |
Exiqon A/S |
Oligonucleotide analogues
|
US20030228597A1
(en)
|
1998-04-13 |
2003-12-11 |
Cowsert Lex M. |
Identification of genetic targets for modulation by oligonucleotides and generation of oligonucleotides for gene modulation
|
US6043352A
(en)
|
1998-08-07 |
2000-03-28 |
Isis Pharmaceuticals, Inc. |
2'-O-Dimethylaminoethyloxyethyl-modified oligonucleotides
|
EP1114179A2
(en)
|
1998-09-15 |
2001-07-11 |
Signalgene Inc. |
Marker at the androgen receptor gene for determining breast cancer susceptibility
|
AU781598B2
(en)
|
1999-04-21 |
2005-06-02 |
Alnylam Pharmaceuticals, Inc. |
Methods and compositions for inhibiting the function of polynucleotide sequences
|
EP1178999B1
(en)
|
1999-05-04 |
2007-03-14 |
Santaris Pharma A/S |
L-ribo-lna analogues
|
US6525191B1
(en)
|
1999-05-11 |
2003-02-25 |
Kanda S. Ramasamy |
Conformationally constrained L-nucleosides
|
EP1244667B1
(en)
|
1999-12-30 |
2006-04-05 |
K.U. Leuven Research & Development |
Cyclohexene nucleic acids
|
US6255110B1
(en)
|
2000-01-21 |
2001-07-03 |
Isis Pharmaceuticals, Inc. |
Antisense modulation of ARA70 expression
|
AU2001244004A1
(en)
|
2000-03-28 |
2001-10-08 |
Signalgene Inc. |
Method for determining osteoporosis susceptibility and/or low bone density and reagents therefor
|
AU2001250572A1
(en)
|
2000-04-07 |
2001-10-23 |
Epigenomics Ag |
Detection of single nucleotide polymorphisms (snp's) and cytosine-methylations
|
EP1282699B1
(en)
|
2000-05-04 |
2012-11-21 |
Sarepta Therapeutics, Inc. |
Splice-region antisense composition and method
|
CA2413417A1
(en)
|
2000-06-28 |
2002-01-03 |
Bristol-Myers Squibb Company |
Selective androgen receptor modulators and methods for their identification, design and use
|
AU2001267008A1
(en)
|
2000-06-28 |
2002-01-08 |
Bristol-Myers Squibb Company |
Cell lines and cell-based assays for identification of androgen receptor modulators
|
RU2003102390A
(ru)
*
|
2000-06-28 |
2004-05-27 |
Бристол-Маерс Сквибб Компани (Us) |
Селективные модуляторы рецептора андрогена и способы их идентификации, изготовления и применения
|
US20040259085A1
(en)
|
2000-07-27 |
2004-12-23 |
Chawnshang Chang |
Methods and compositions for predicting prostate cancer
|
US20020165381A1
(en)
|
2000-11-30 |
2002-11-07 |
Isabelle Ahrens-Fath |
Human androgen receptor variants
|
JP2002247986A
(ja)
|
2001-02-23 |
2002-09-03 |
Mitsui Chemicals Inc |
性ホルモン受容体作用評価に有用な細胞
|
US20070021360A1
(en)
|
2001-04-24 |
2007-01-25 |
Nyce Jonathan W |
Compositions, formulations and kit with anti-sense oligonucleotide and anti-inflammatory steroid and/or obiquinone for treatment of respiratory and lung disesase
|
US20050159376A1
(en)
|
2002-02-20 |
2005-07-21 |
Slrna Therapeutics, Inc. |
RNA interference mediated inhibition 5-alpha reductase and androgen receptor gene expression using short interfering nucleic acid (siNA)
|
WO2003004602A2
(en)
|
2001-07-03 |
2003-01-16 |
Isis Pharmaceuticals, Inc. |
Nuclease resistant chimeric oligonucleotides
|
US6680342B2
(en)
|
2001-09-20 |
2004-01-20 |
Mayo Foundation For Medical Education And Research |
Methods and compositions for inhibiting the proliferation of prostate cancer cells
|
FR2832154B1
(fr)
|
2001-11-09 |
2007-03-16 |
Centre Nat Rech Scient |
Oligonucleotides inhibiteurs et leur utilisation pour reprimer specifiquement un gene
|
US6861432B2
(en)
|
2001-11-23 |
2005-03-01 |
Schering Aktiengesellschaft |
Piperazine derivatives that destabilize androgen receptors
|
JP2004008140A
(ja)
|
2002-06-10 |
2004-01-15 |
Sumitomo Chem Co Ltd |
変異型アンドロゲンレセプターおよびその活性評価用細胞
|
EP1540004A4
(en)
|
2002-07-31 |
2007-10-03 |
Nucleonics Inc |
DOUBLE-STRING RNA STRUCTURES AND CONSTRUCTS AND METHOD FOR THE PRODUCTION AND USE THEREOF
|
US20060035344A1
(en)
|
2002-10-18 |
2006-02-16 |
Pachuk Catherine J |
Double-stranded rna structures and constructs, and methods for generating and using the same
|
JP2006513159A
(ja)
|
2002-11-01 |
2006-04-20 |
メルク エンド カムパニー インコーポレーテッド |
アンドロゲン受容体モジュレーターとしてのカルボニルアミノ−ベンズイミダゾール誘導体
|
AU2003291755A1
(en)
|
2002-11-05 |
2004-06-07 |
Isis Pharmaceuticals, Inc. |
Oligomers comprising modified bases for binding cytosine and uracil or thymine and their use
|
AU2003291753B2
(en)
|
2002-11-05 |
2010-07-08 |
Isis Pharmaceuticals, Inc. |
Polycyclic sugar surrogate-containing oligomeric compounds and compositions for use in gene modulation
|
ATE517992T1
(de)
|
2002-11-14 |
2011-08-15 |
Dharmacon Inc |
Funktionelle und hyperfunktionelle sirna
|
US6673661B1
(en)
|
2002-12-20 |
2004-01-06 |
Taiwan Semiconductor Manufacturing Co., Ltd. |
Self-aligned method for forming dual gate thin film transistor (TFT) device
|
US20070141009A1
(en)
|
2003-01-03 |
2007-06-21 |
Shaharyar Khan |
Sirna mediated post-transriptional gene silencing of genes involved in alopecia
|
CA2511089A1
(en)
|
2003-01-17 |
2004-08-05 |
Warner-Lambert Company Llc |
Androgen receptor antagonists
|
JP2004254601A
(ja)
|
2003-02-26 |
2004-09-16 |
Sumitomo Chem Co Ltd |
変異型アンドロゲンレセプターおよびその活性評価用細胞
|
JP2004254600A
(ja)
|
2003-02-26 |
2004-09-16 |
Sumitomo Chem Co Ltd |
変異型アンドロゲンレセプターおよびその活性評価用細胞
|
DE10322108B4
(de)
|
2003-05-09 |
2008-12-11 |
Bayer Schering Pharma Aktiengesellschaft |
Antiandrogene Pyrrolidine mit tumorhemmender Wirksamkeit
|
WO2004106356A1
(en)
|
2003-05-27 |
2004-12-09 |
Syddansk Universitet |
Functionalized nucleotide derivatives
|
US7427672B2
(en)
|
2003-08-28 |
2008-09-23 |
Takeshi Imanishi |
Artificial nucleic acids of n-o bond crosslinkage type
|
AU2004274021B2
(en)
|
2003-09-18 |
2009-08-13 |
Isis Pharmaceuticals, Inc. |
4'-thionucleosides and oligomeric compounds
|
US20050164970A1
(en)
|
2003-12-22 |
2005-07-28 |
University Of Kansas Medical Center |
Method for treating prostate cancer using siRNA duplex for androgen receptor
|
US20050244851A1
(en)
|
2004-01-13 |
2005-11-03 |
Affymetrix, Inc. |
Methods of analysis of alternative splicing in human
|
CA2558682A1
(en)
|
2004-02-20 |
2005-09-01 |
Genesis Research And Development Corporation Limited |
Targeted delivery of rna interference molecules for the treatment of ige-mediated disorders
|
US7696241B2
(en)
|
2004-03-04 |
2010-04-13 |
Bristol-Myers Squibb Company |
Bicyclic compounds as modulators of androgen receptor function and method
|
EP1752536A4
(en)
|
2004-05-11 |
2008-04-16 |
Alphagen Co Ltd |
POLYNUCLEOTIDE CAUSING RNA INTERFERENCE AND METHOD OF REGULATING GENE EXPRESSION WITH THE USE OF THE SAME
|
WO2005115361A2
(en)
|
2004-05-17 |
2005-12-08 |
Acadia Pharmaceuticals Inc. |
Androgen receptor modulators and method of treating disease using the same
|
DE102004025881A1
(de)
|
2004-05-19 |
2006-01-05 |
Beiersdorf Ag |
Oligoribonukleotide zur Beeinflussung des Haarwachstums
|
JP2008501693A
(ja)
|
2004-06-03 |
2008-01-24 |
アイシス ファーマシューティカルズ、インク. |
遺伝子調節で使用するための個別に調節された鎖を有する二本鎖組成物
|
CA2576233C
(en)
|
2004-08-10 |
2016-03-15 |
Alnylam Pharmaceuticals, Inc. |
Conjugate comprising an antagomir and a ligand
|
US20080261905A1
(en)
|
2004-11-08 |
2008-10-23 |
K.U. Leuven Research And Development |
Modified Nucleosides for Rna Interference
|
WO2006086345A2
(en)
|
2005-02-07 |
2006-08-17 |
The Trustees Of Columbia University In The City Of New York |
Methods to treat or prevent hormone-resistant prostate cancer using sirna specific for protocadherin-pc, or other inhibitors of protocadherin-pc expression or activity
|
US8795987B2
(en)
|
2005-02-11 |
2014-08-05 |
International Business Machines Corporation |
Ribonucleic acid interference molecules of Oryza sativa
|
US20080125583A1
(en)
|
2005-02-11 |
2008-05-29 |
International Business Machines Corporation |
Ribonucleic acid interference molecules
|
US8912317B2
(en)
|
2005-02-11 |
2014-12-16 |
International Business Machines Corporation |
Ribonucleic acid interference molecules of Arabidopsis thaliana
|
US20070213293A1
(en)
|
2005-04-08 |
2007-09-13 |
Nastech Pharmaceutical Company Inc. |
Rnai therapeutic for respiratory virus infection
|
US7709517B2
(en)
|
2005-05-13 |
2010-05-04 |
The Regents Of The University Of California |
Diarylhydantoin compounds
|
WO2007014370A2
(en)
|
2005-07-28 |
2007-02-01 |
University Of Delaware |
Small regulatory rnas and methods of use
|
US7700567B2
(en)
|
2005-09-29 |
2010-04-20 |
Supergen, Inc. |
Oligonucleotide analogues incorporating 5-aza-cytosine therein
|
AU2007211080B9
(en)
|
2006-01-27 |
2012-05-03 |
Isis Pharmaceuticals, Inc. |
6-modified bicyclic nucleic acid analogs
|
JP4961549B2
(ja)
|
2006-02-16 |
2012-06-27 |
国立大学法人愛媛大学 |
アンドロゲン受容体遺伝子に特異的なsiRNA
|
US8178503B2
(en)
|
2006-03-03 |
2012-05-15 |
International Business Machines Corporation |
Ribonucleic acid interference molecules and binding sites derived by analyzing intergenic and intronic regions of genomes
|
PT2656841T
(pt)
|
2006-03-27 |
2016-09-28 |
Univ California |
Modulador do recetor de androgénios para o tratamento de cancro da próstata e doenças associadas ao recetor de androgénios
|
JP2007282598A
(ja)
|
2006-04-19 |
2007-11-01 |
Japan Health Science Foundation |
性分化異常症診断マーカー
|
ES2389737T3
(es)
|
2006-05-11 |
2012-10-31 |
Isis Pharmaceuticals, Inc. |
Análogos de ácidos nucleicos bicíclicos modificados en 5'
|
JP4798093B2
(ja)
|
2006-08-04 |
2011-10-19 |
日産自動車株式会社 |
流体改質装置及びこれを用いた流体改質方法
|
AR055648A1
(es)
|
2006-09-21 |
2007-08-29 |
Gen Med Sa |
Un oligonucleotido de rna de doble cadena una composicion farmaceutica o cosmetica que lo comprende y uso del mismo enla preparacion de un medicamento para el tratamiento de enfermedades relacionadas con el metabolismo de androgenos
|
WO2008070862A2
(en)
|
2006-12-07 |
2008-06-12 |
Biocept, Inc. |
Non-invasive prenatal genetic screen
|
US7960435B2
(en)
|
2006-12-15 |
2011-06-14 |
University Of Maryland, Baltimore |
Anti-cancer agents and androgen inhibition activity compound
|
US20100190837A1
(en)
|
2007-02-15 |
2010-07-29 |
Isis Pharmaceuticals, Inc. |
5'-Substituted-2-F' Modified Nucleosides and Oligomeric Compounds Prepared Therefrom
|
WO2008119015A2
(en)
|
2007-03-27 |
2008-10-02 |
Sloan-Kettering Institute For Cancer Research |
Synthesis of thiohydantoins
|
EP2170917B1
(en)
|
2007-05-30 |
2012-06-27 |
Isis Pharmaceuticals, Inc. |
N-substituted-aminomethylene bridged bicyclic nucleic acid analogs
|
EP2173760B2
(en)
|
2007-06-08 |
2015-11-04 |
Isis Pharmaceuticals, Inc. |
Carbocyclic bicyclic nucleic acid analogs
|
DK2176280T4
(en)
|
2007-07-05 |
2015-07-20 |
Isis Pharmaceuticals Inc |
6-Disubstituerede bicykliske nukleinsyreanaloge
|
CA2701128A1
(en)
*
|
2007-10-01 |
2009-04-09 |
Isis Pharmaceuticals, Inc. |
Antisense modulation of fibroblast growth factor receptor 4 expression
|
WO2009067647A1
(en)
|
2007-11-21 |
2009-05-28 |
Isis Pharmaceuticals, Inc. |
Carbocyclic alpha-l-bicyclic nucleic acid analogs
|
US8450290B2
(en)
|
2007-11-26 |
2013-05-28 |
Enzon Pharmaceuticals, Inc. |
Methods for treating androgen receptor dependent disorders including cancers
|
TW200930382A
(en)
*
|
2007-11-26 |
2009-07-16 |
Santaris Pharma As |
LNA antagonists targeting the androgen receptor
|
BRPI0821676A2
(pt)
|
2007-12-21 |
2015-06-16 |
Astrazeneca Ab |
Composto, composição farmacêutica, e, processo para a preparação dos compostos.
|
EP2265627A2
(en)
|
2008-02-07 |
2010-12-29 |
Isis Pharmaceuticals, Inc. |
Bicyclic cyclohexitol nucleic acid analogs
|
EP2255190A4
(en)
|
2008-02-12 |
2011-05-04 |
Brigham & Womens Hospital |
FISH TEST FOR EML4-ALK FUSION IN LUNG CANCER
|
FR2929292A1
(fr)
|
2008-03-28 |
2009-10-02 |
Exonhit Therapeutics S A Sa |
Procede et methodes de diagnostic de la maladie d'alzheimer
|
US20090282496A1
(en)
|
2008-04-04 |
2009-11-12 |
University Of Rochester Medical Center |
Androgen Receptor Related Methods for Treating Bladder Cancer
|
EP3062106B1
(en)
|
2008-04-16 |
2020-11-11 |
The Johns Hopkins University |
Method for determining androgen receptor variants in prostate cancer
|
EP3081648A1
(en)
|
2008-08-25 |
2016-10-19 |
Excaliard Pharmaceuticals, Inc. |
Antisense oligonucleotides directed against connective tissue growth factor and uses thereof
|
US8133724B2
(en)
|
2008-09-17 |
2012-03-13 |
University Of Maryland, Baltimore |
Human androgen receptor alternative splice variants as biomarkers and therapeutic targets
|
WO2010036698A1
(en)
|
2008-09-24 |
2010-04-01 |
Isis Pharmaceuticals, Inc. |
Substituted alpha-l-bicyclic nucleosides
|
WO2010036696A1
(en)
|
2008-09-24 |
2010-04-01 |
Isis Pharmaceuticals, Inc. |
Cyclohexenyl nucleic acid analogs
|
WO2010062914A1
(en)
|
2008-11-26 |
2010-06-03 |
The Johns Hopkins University |
Methods for identifying cancer risk
|
JP2010148501A
(ja)
|
2008-11-28 |
2010-07-08 |
Hisamitsu Pharmaceut Co Inc |
がんマーカー、及び、がんの治療剤
|
CA2767231A1
(en)
|
2009-07-06 |
2011-01-13 |
Alnylam Pharmaceuticals, Inc. |
Cell-based bioprocessing
|
EP2451940A4
(en)
|
2009-07-06 |
2013-08-28 |
Alnylam Pharmaceuticals Inc |
bioprocessing
|
ES2668380T3
(es)
|
2010-02-16 |
2018-05-17 |
Aragon Pharmaceuticals, Inc. |
Moduladores de receptores de andrógenos y sus usos
|
WO2011112581A1
(en)
|
2010-03-08 |
2011-09-15 |
Regents Of The University Of Minnesota |
Androgen receptor isoforms and methods
|
EP2545173A2
(en)
|
2010-03-12 |
2013-01-16 |
Sarepta Therapeutics, Inc. |
Antisense modulation of nuclear hormone receptors
|
KR101869570B1
(ko)
|
2010-04-28 |
2018-06-20 |
아이오니스 파마수티컬즈, 인코포레이티드 |
변형된 뉴클레오사이드 및 그로부터 제조된 올리고머 화합물
|
KR20200133284A
(ko)
|
2010-05-28 |
2020-11-26 |
사렙타 쎄러퓨틱스, 인코퍼레이티드 |
변형된 서브유니트간 결합 및/또는 말단 그룹을 갖는 올리고뉴클레오타이드 유사체
|
WO2012005898A2
(en)
|
2010-06-15 |
2012-01-12 |
Alnylam Pharmaceuticals, Inc. |
Chinese hamster ovary (cho) cell transcriptome, corresponding sirnas and uses thereof
|
WO2012006241A2
(en)
|
2010-07-06 |
2012-01-12 |
Dicerna Pharmaceuticals, Inc. |
Methods and compositions for the specific inhibition of androgen receptor by double-stranded rna
|
CN106434648A
(zh)
*
|
2010-07-19 |
2017-02-22 |
F·C·贝内特 |
肌强直性营养障碍蛋白激酶(dmpk)表达的调节
|
WO2012018881A2
(en)
|
2010-08-03 |
2012-02-09 |
Alnylam Pharmaceuticals, Inc. |
Methods and compositions for the regulation of rna
|
EP2646553A4
(en)
|
2010-11-12 |
2015-01-07 |
Santaris Pharma As |
COMPOSITIONS AND METHODS OF TREATING ANDROGEN RECEPTOR DEPENDENT DISORDERS INCLUDING CANCER
|
DK2655621T3
(en)
|
2010-12-20 |
2018-08-13 |
Massachusetts Gen Hospital |
Polycomb-associated non-coding RNAS
|
EP2670411B1
(en)
|
2011-02-02 |
2019-04-10 |
Excaliard Pharmaceuticals, Inc. |
Antisense compounds targeting connective tissue growth factor (ctgf) for use in a method of treating keloids or hypertrophic scars
|
EP2673361B1
(en)
|
2011-02-08 |
2016-04-13 |
Ionis Pharmaceuticals, Inc. |
Oligomeric compounds comprising bicyclic nucleotides and uses thereof
|
US20140031257A1
(en)
*
|
2011-03-10 |
2014-01-30 |
Oslo Universitetssykehus Hf |
Methods and biomarkers for detection of gastrointestinal cancers
|
EP2751270B1
(en)
|
2011-08-29 |
2018-08-22 |
Ionis Pharmaceuticals, Inc. |
Oligomer-conjugate complexes and their use
|
EP3330278A1
(en)
|
2012-02-08 |
2018-06-06 |
Ionis Pharmaceuticals, Inc. |
Modulation of rna by repeat targeting
|
US9778706B2
(en)
|
2012-02-24 |
2017-10-03 |
Blackberry Limited |
Peekable user interface on a portable electronic device
|
US9984408B1
(en)
|
2012-05-30 |
2018-05-29 |
Amazon Technologies, Inc. |
Method, medium, and system for live video cooperative shopping
|
US9175291B2
(en)
|
2012-10-11 |
2015-11-03 |
Isis Pharmaceuticals Inc. |
Modulation of androgen receptor expression
|